ACE Inhibitors News and Research

RSS
ACE inhibitors act to reduce hypertension by interfering with the conversion of angiotensin I to artery-constricting angiotensin II. Blocking the production of angiotensin II results in arterial vasodilation and an accompanying reduction in blood pressure. ACE inhibitors currently are recommended as first-line therapy for hypertension in certain patient populations, because of their safety and efficacy.
ESC welcomes 'intriguing' study on heart failure

ESC welcomes 'intriguing' study on heart failure

Ethanol, nonalcoholic compounds in red wine may reduce risk of vascular disease

Ethanol, nonalcoholic compounds in red wine may reduce risk of vascular disease

Researchers publish first detailed figures that show risk of Rasilez and ACE inhibitors or ARBs

Researchers publish first detailed figures that show risk of Rasilez and ACE inhibitors or ARBs

Cardiologist measures risk factors associated with CR

Cardiologist measures risk factors associated with CR

ACE inhibitors, ARBs have different effects on heart health of dialysis patients

ACE inhibitors, ARBs have different effects on heart health of dialysis patients

Combination of antipsychotic and antidepressant drugs may increase risk of CV mortality

Combination of antipsychotic and antidepressant drugs may increase risk of CV mortality

Eliminating drug co-pays improves medication adherence in heart attack patients

Eliminating drug co-pays improves medication adherence in heart attack patients

No unique link between first-trimester ACE inhibitor use and birth defects

No unique link between first-trimester ACE inhibitor use and birth defects

Seaweed lipid extracts could reduce risk of heart disease

Seaweed lipid extracts could reduce risk of heart disease

Heart attack patients with psoriasis more likely to die from cardiovascular disease

Heart attack patients with psoriasis more likely to die from cardiovascular disease

Cheap medicines could prevent huge number of deaths from heart attacks, strokes

Cheap medicines could prevent huge number of deaths from heart attacks, strokes

AHRQ's new Spanish-language guide on heart medications

AHRQ's new Spanish-language guide on heart medications

Dyax initiates ecallantide Phase 2 trial for ACE inhibitor-induced angioedema

Dyax initiates ecallantide Phase 2 trial for ACE inhibitor-induced angioedema

Britain’s prescription drug use statistics revealed

Britain’s prescription drug use statistics revealed

Egg yolks may protect against cardiovascular disease and cancer

Egg yolks may protect against cardiovascular disease and cancer

ACAAI issues updated guidelines for treating stinging insect hypersensitivity

ACAAI issues updated guidelines for treating stinging insect hypersensitivity

New study identifies less invasive therapy for ACE inhibitor side-effects

New study identifies less invasive therapy for ACE inhibitor side-effects

Ramipril can effectively reduce risk of ESRD in obese patients

Ramipril can effectively reduce risk of ESRD in obese patients

Study finds increase in implementation of evidence-based therapies for myocardial infarction

Study finds increase in implementation of evidence-based therapies for myocardial infarction

ACC/AHA release consensus document to help clinicians reduce risk of hypertension in older adults

ACC/AHA release consensus document to help clinicians reduce risk of hypertension in older adults

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.